IP Verse

Pegylated Drug-Linkers For Improved Ligand-Drug Conjugate Pharmacokinetics

Patent No. EP3057585 (titled "Pegylated Drug-Linkers For Improved Ligand-Drug Conjugate Pharmacokinetics") was filed by Seagen on Oct 14, 2014. The application was issued on Jul 22, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
EUROPEAN OPPOSITIONSApr 22, 2021BASSIL

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3057585

SEAGEN
Application Number
EP14853953A
Filing Date
Oct 14, 2014
Status
Granted And Under Opposition
Jun 19, 2020
Publication Date
Jul 22, 2020
External Links
Slate, Register , Google Patents